Strategic Approaches to Biomarker Testing in NSCLC: Optimal Timing
Experts reflect on the evolving landscape of biomarker testing in lung cancer, examining its crucial role in treatment decisions and advancements in perioperative and adjuvant therapies.
Precision Medicine Biomarker Testing Non Small Cell Lung Cancer Lung Cancer Lung Cancer Treatment Perioperative Therapy
Source: onclive.com